SYBRAVA

This brand name is authorized in Nigeria.

Active ingredients

The drug SYBRAVA contains one active pharmaceutical ingredient (API):

1	Inclisiran UNII UPC6BTX7PY - INCLISIRAN SODIUM
	Inclisiran is a cholesterol-lowering, double-stranded, small interfering ribonucleic acid (siRNA), conjugated on the sense strand with triantennary N-acetylgalactosamine (GalNAc) to facilitate uptake by hepatocytes. It is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet.
	Read more about Inclisiran

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100313	Solution for injection	Sybrava 284 mg/1.5 mL Solution for Injection INJ_SOL 284 mg/1.5 mL 1 x 1's (Prefilled Syringe)	Solution for injection. The solution is clear, colorless to pale yellow and essentially free of particulates.	24/11/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AX16		C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AX Other lipid modifying agents
Discover more medicines within C10AX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100313